Home
    Preliminary Topics
    Registration
    Accommodation
    Contact
Home
Welcome Note
Committees
Local Advisory Board
Faculty
Timetable
Scientific Program
Poster Presentations
Poster Presentation Guidelines
CME
Sponsorship & Exhibition
Sponsors
Exhibitors
Registration
Accommodation
Hotel Rey Juan Carlos
Hotel Husa Illa
Hotel Senator Barcelona
General Information
Before you travel...
Invitation Letter
About Barcelona
Partners
Links
COPHy 2010
COPHy 2010 Sponsors
The 2nd World Congress on
Controversies in Ophthalmology (COPHy)

Catalonia Palace of Congresses, Barcelona, Spain, March 3-6, 2011
Choose your category in order to view all related Sessions. Select by category

Friday, March 4, 2011

Time   Hall
 
Session 1
08:30-10:00
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits I

Chairpersons: G. Rose, UK & R. Medel, Spain
Capsule:  Diagnosis and treatment of lacrimal system abnormalities are still under debate
A
08:30-09:00
Welcome: G. Rose, UK
 
Debate: Dacryocystography has almost no role in the routine assessment of lacrimal drainage problems
A
08:30-08:40
D. Verity, UK
A
08:40-08:50
Con
J. Prat Bartomeu, Spain
A
08:50-09:00
Discussion
A
09:00-09:30
Debate: Integrated (porous) orbital implants have no measurable advantage in socket surgery
A
09:00-09:10
Pro 
G. Rose, UK
A
09:10-09:20
Con
R. Guthoff, Germany
A
09:20-09:30 Discussion A
09:30-10:00
Short Debates
1) Implants should be placed at the time of primary evisceration for infective endophthalmitis
2) Endoscopic brow-lifts are of doubtful value and have poor long-term outcome
3) There is no role of biocorporal flaps in the surgery for soley orbital disease
4) Artificial eyes should be removed daily for cleaning, rather than being left for long periods without attention
Moderator:
N. Rosen, Israel
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
R. Medel, Spain
G. Rose, UK
J. Prat-Bartomeu, Spain
W. van den Bosch, The Netherlands
D. Verity, UK
A
 
10:00-10:30 Coffee Break A
10:30-12:00
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
 
Chairpersons:
A. Loewenstein, Israel & S. Lightman, UK
A
10:30-10:45
Lecture: More to ME than meets the eye
J. Ambati, USA
A
10:45-10:50
Lecture: Steroid vs. laser in RVO
N. Bressler, USA
A
10:50-10:55
Lecture: Anti-VEGF in RVO
A. Augustin, Germany
A
10:55-11:00
Lecture: Steroids in RVO
F. Bandello, Italy
A
11:00-11:30
Lecture: Analyzing apples to apples in clinical trials - introducing the rationale for COMO
A. Loewenstein, Israel
A
11:30-11:45
Lecture: Perspectives of steroids in the management of ME
S. Lightman, UK
A
 
12:00-13:00 Lunch Break A
 
Session 2
13:00-14:30
Glaucoma I

Chairpersons: A. Heijl, Sweden & H.D. Jampel, USA
Capsule: Preferred glaucoma screening methods
A
13:00-13:30
Debate: Selective perimetry is often useful
A
13:00-13:10
D. Friedman, USA
A
13:10-13:20
A. Heijl, Sweden
A
13:20-13:30
Discussion
A
13:30-14:00
Debate: Screening for glaucoma
A
13:30-13:40
Justified
D. Friedman, USA
A
13:40-13:50
H.D. Jampel, USA
A
13:50-14:00 Discussion A
14:00-14:30
Debate: IOP fluctuation
A
14:00-14:10
H.D. Jampel, USA
A
14:10-14:20
A. Heijl, Sweden
A
14:20-14:30
Discussion
A
 
14:30-15:00 Coffee Break A
 
Session 3
15:00-16:30
Glaucoma II

Chairpersons:
D. Friedman, USA & A. Heijl, Sweden
Capsule:
Various treatment modalities in glaucoma - still under debate
A
15:00-15:30 A
15:00-15:10
Treat
L. Rossetti, Italy
A
15:10-15:20
Don't treat
G. Sunaric Megevand, Switzerland
A
15:20-15:30
Discussion
A
15:30-16:00 Debate: First-line treatments in open-angle glaucoma 
A
15:30-15:40

Trabeculectomy – surgical intervention
H.D. Jampel, USA

A
15:40-15:50 SLT
S. Melamed, Israel
A
15:50-16:00 Other
P. Foster, UK
A
16:00-16:30
Debate: Treatment of closed angle glaucoma
A
16:00-16:10
Iridotomy
D. Friedman, USA
A
16:10-16:20
P. Foster, UK
A
16:20-16:30
Discussion
A
 
Session 4
16:30-18:00
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits II

Chairpersons:
G. Rose, UK & D. Verity, UK
Capsule:
Debates related to orbital disease
A
16:30-17:00
Welcome: G. Rose, UK & D. Verity, UK
 
A
16:30-16:40
Yes
W. ven den Bosch, The Netherlands
A
16:40-16:50
M. Gonzalez-Candial, Spain
A
16:50-17:00
Discussion
A
17:00-17:30 A
17:00-17:10
Yes
N. Rosen, Israel
A
17:10-17:20
No
R. Hermida, Spain
A
17:20-17:30 Discussion A
17:30-18:00
Short Debates
1) Lacrimal sac abcesses should be drained and DCR deferred until inflammation settles
2) Orbital wall fractures should generally have early repair
3) Silicone rods are the preferred brow suspension material for patients with severe myopathic ptosis
4) Anti-metabolites should routinely be used during revisional lacrimal drainage surgery
5) DCR is a nasal operation and should be performed by ENT surgeons!
Moderator:
R. Medel, Spaihn
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
J. Prat-Bartomeu, Spain
G. Rose, UK
N. Rosen, Israel
W. van den Bosch, The Netherlands
D. Verity, UK
A
 
Session 5
08:30-10:00
Pediatrics I: Strabismus

Chairpersons:
P. Nucci, Italy & K.K. Nischal, UK
Capsule:
Questionable strabismus treatment modalities
B
08:30-09:15
Panel Discussion: Accommodative Estropia
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
B
09:15-10:00
Panel Discussion: Brown Syndrome and Duane Syndrome
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
B
 
10:00-10:30 Coffee Break B
10:30-12:00 Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
A
 
12:00-13:00 Lunch Break B
 
Session 6
13:00-14:30

Trauma I

Chairpersons:
F. Kuhn, USA & J. Moisseiev, Israel
Capsule:
Ocular trauma treatment
B
13:00-13:45
Update Lectures
B
13:00-13:10
N. Miller, USA
B
13:10-13:20
W. Schrader, Germany
B
13:20-13:30
D. Sachs, Israel
B
13:30-13:45
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany
B
13:45-14:30
Debate: Enucleation and evisceration in the management of severe eye injury
B
13:45-14:00
N. Rosen, Israel
B
14:00-14:15
F. Kuhn, USA
B
14:15-14:30
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany
B
 
14:30-15:00 Coffee Break B
 
Session 7
15:00-16:30

Trauma II

Chairpersons:
J. Moisseiev, Israel & F. Kuhn, USA
Capsule:
Specific situations in ocular trauma
B
15:00-15:45
Update Lectures
B
15:00-15:15
J. Moisseiev, Israel
B
15:15-15:30
P. Sternberg, USA
B
15:30-15:45
Discussion
B
15:45-16:30
Case Presentation and Panel Discussion: Anterior and posterior segment
Moderators:
J. Moisseiev, Israel & F. Kuhn, USA
Panel:
A. Barak, Israel
W. Mieler, USA
W. Schrader, Germany
P. Sternberg, USA
B
 
Session 8
08:30-10:00
Cataract: Complicated Situations in Cataract Sugery I
 
Chairpersons: W.J. Stark, USA & E. Assia, Israel
Capsule:
Cataract surgery: Problems still to be solved
C
08:30-09:00
Debate: IFIS: Surgical thrill or no big deal?
C
08:30-08:40
No more than some minor modifications
R. Barraquer, Spain
C
08:40-08:50
Z. Biro, Hungary
C
08:50-09:00
Discussion
C
09:00-09:30
Debate: Astigmatism correction should be performed during lens surgery or not?
C
09:00-09:10
J. Alio, Spain
C
09:10-09:20
Yes, there are
TBA
C
09:20-09:30
Discussion
C
09:30-09:45
W.J. Stark, USA
C
09:45-10:00 Lecture: Femtosecond laser cataract surgery
J. AlioSpain
C
 
10:00-10:30 Coffee Break C
10:30-12:00
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
A
 
12:00-13:00 Lunch Break C
 
Session 9
13:00-14:30

Medical Retina I

Chairpersons:
G. Coscas, France & F. Bandello, Italy
Capsule:
AMD - Lucentis? Avastin? VEGF trap? Others?
C
13:00-13:30 Debate: The role of adjunctive treatment in AMD treatment C
13:00-13:07
E. Souied, France
C
13:07-13:15
A. Augustin, Germany
C
13:15-13:23
Radiation adjunctive therapy may be helpful
P. Dugel, USA
C
13:23-13:35
Panel Discussion
Moderator:
U. Chakravarthy, UK
Panel:
G. Coscas, France
P. Dugel, USA
A. Loewenstein, Israel
G. Soubrane, France
C
13:30-14:00
Debate: Avastin vs. Lucentis vs. others
C
13:30-13:38
P. Lanzetta, Italy
C
13:38-13:46
U. Schmidt-Erfurth, Austria
C
13:46-13:53
New players in the game
G. Soubrane, France
C
13:53-14:00
Panel Discussion
Moderator:
N. Bressler, USA
Panel:
F. Boscia, Italy
U. Chakravarthy, UK
P. Dugel, USA
C
14:00-14:30
Debate: Optimal treatment for CNV secondary to AMD
C
13:00-14:07
Monthy anti VEGF
S. Bressler, USA
C
14:07-14:15
F. Bandello, Italy
C
14:15-14:23
Panel Discussion
Moderator:
C
14:23-14:35
S. Bressler, USA
Panel:
U. Chakravarthy, UK
P. Dugel, USA
P. Lanzetta, Italy
A. Loewenstein, Israel
G. Soubrane, France
C
 
14:00-14:30 Coffee Break C
 
Session 10
15:00-16:30

Cataract: Complicated Situations in Cataract Surgery II

Chairpersons:
E. Assia, Israel & W.J. Stark, USA
Capsule:
Premium IOLs: Advantages and concerns
C
15:00-15:30
Debate: Management of cases with weak zonules
C
15:00-15:15
W.J. Stark, USA
C
15:15-15:25
E. Assia, Israel
C
15:25-15:30
Discussion
C
15:30-16:00
Debate: Premium lens
C
15:30-15:40
Accommodative IOLs
J. Alio, Spain
C
15:40-15:50
W.J. Stark, USA
C
15:50-16:00
Discussion
C
16:00-16:30
Panel Discussion: The premium IOL patient: Happy or unhappy?
Moderator: E. Assia, Israel
Panel:
J. Alio, Spain
Z. Biro, Hungary
W.J. Stark, USA
C

Saturday, March 5, 2011

Time   Hall
 
Session 11
08:30-10:00
Tumors I
 
Chairpersons:
L. Zografos, Switzerland & J. Pe'er, Israel
Capsule: Iris tumors - diagnostic and therapeutic considerations
A
08:30-08:50 Debate: Incisional biopsy of the iris A
08:30-08:38
L. Desjardins, France
A
08:38-08:46
N. Bechrakis, Austria
A
08:46-08:50 Discussion A
08:50-09:10 Debate: Therapeutic approach to iris melanomas A
08:50-08:58
Primary surgery
T. Kivela, Finland
A
08:58-09:06
B. Damato, UK
A
09:06-09:10 Discussion A
09:10-09:30 Debate: Circumscribed vs. Global irradiation of anterior segment in iris melanomas A
09:10-09:18
L. Desjardins, France
A
09:18-09:26
Global irradiation of anterior segment
L. Zografos, Switzerland
A
09:26-09:30 Discussion A
09:30-10:00
Controversies in the diagnostic approach and management of iris tumors
Discussion on selected Case Reprots
Presenter:
L. Zografos, Swizterland
Discussant:
J. Pe'er, Israel
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
A
 
10:00-10:30 Coffee Break A
 
Session 12
10:30-12:00
Socioeconomics
 
Chairperson: N. Bressler, USA
Capsule:
Ethical concerns
A
10:30-11:15
Part I
A
10:30-10:45
Lecture: Is participation in speakers' bureaus unprofessional conduct for physicians who proivde continuing medical education?
N. Bressler, USA
A
10:45-11:00
H.D. Jampel, USA
A
11:00-11:15
Discussion
A
11:15-12:00
Part II
A
11:15-11:30
Lecture: Pros and Cons regarding industry interactions with physicians in clinical research
N. Bressler, USA
A
11:30-11:50
G. Barbash, Israel
A
11:50-12:00
Discussion
A
 
12:00-13:00
Glaucoma: A neurodegenerative disease
Lunch Session
(Garden Pavilion)
A
12:10-12:20
Lecture: Glaucoma - a neurodegenerative disease
L. Levin, Canada
A
12:20-12:30
Lecture: Measuring of glaucoma progression
A. Heijl, Sweden
A
12:30-12:40
Lecture: Managing IOP - the most important risk factor
L. Rossetti, Italy
A
12:40-12:50
Lecture: What to do when IOP lowering isn't enough
S. Gandolfi, Italy
A
12:50-13:00
Lecture: Mechanisms behind therapeutic outcomes
F. Cordeiro, UK
A
 
Session 13
13:00-14:45
Glaucoma III
 
Chairpersons: S. Gandolfi, Italy & L. Rossetti, Italy
Capsule:
Hot glaucoma topics in the pipeline
A
13:00-13:30
Debate: Medical Management of Glaucoma - Neuroprotection
A
13:00-13:10
Neuroprotection is a viable 1st line option for glaucoma management
L. Levin, Canada
A
13:10-13:20
Neuroprotection should not be part of glaucoma management
F. Cordeiro, UK
A
13:20-13:45
Panel Discussion on NP: To be or not to be taht is the Question
Moderator: L. Rossetti, Italy
Panel:
F. Cordeiro, UK
L. Levin, Canada
A
13:45-14:30
Debate: Structure and Function in Measuring rate of progression in Glaucoma
A
13:45-13:55
Imaging is the easiest and most cost effective way for following glaucoma progression
TBA
A
13:55-14:00
Performing imaging or photography in manifest glaucoma is a waste of resources - instead monitoring using visual fields should be done more often
L. Rossetti, Italy
A
14:00-14:30
Panel Discussion
Moderator: A. Heijl, Sweden
Panel:
S. Kurtz, Israel
L. Rossetti, Italy
A
 
14:30-15:00 Coffee Break A
15:00-16:30

Symposium

SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
 
Moderator: 
A. Cruess, Canada
 
Lecture: European regulation and the practicing ophthalmologist 
P. Bogaert, Belgium
 
Lecture: The regulatory process in action: A case study
K. Khunti, UK
 
Lecture: Understanding the safety profile of anti-VEGF's
P. Kaiser, USA
   
Debate: Off label prescribing, patient safety and the current environment
Panel & audience
 
Summary
Moderator
A
 
Session 14
16:30-18:00
Neuro-Ophthalmology I
 
Chairpersons: N. Miller, USA & M. Burdon, UK
Capsule: Optic neuropathy
A
16:30-17:15
Symposium on the treatment of traumatic optic neuropathy
A. Lee, USA
A. Arnold, USA
N. Miller, USA
Observation is best
M. Burdon, UK
A
17:15-18:00
Case Presentations
1) Acute isolated 6th nerve palsy in an elderly vasculopath
A. Arnold, USA
A. Kesler, Israel
 
2) Ocular migraine
A. Arnold, USA
 
3) Acute 3rd nerve palsy
A. Arnold, USA
B. Sanchez Dalmau, Spain
 
4) Acquired nystagmus in a patient with MS
M. Burdon, UK
  
5) A patient with IIH and transverse sinus stenosis
L. Castillo, Spain
A. Lee, USA
 
6) A patient with double vision from GCA
A. Kesler, Israel
S. Muñoz, Spain
   
7) A patient with long-standing optic atrophy
Open panel
 
A
 
Session 15
08:30-10:00
Imaging I
 
Chairpersons: H. Scholl, USA & G. Staurenghi, Italy
Capsule:
Fundus autofluorescence and beyond
B
08:30-09:15
Debate: Role of autofluorescence for monitoring progression of geographic atrophy in AMD?
B
08:30-08:45
E. Midena, Italy
B
08:45-09:00
U. Chakravarthy
B
09:00-09:15 Discussion B
09:15-10:00
Lecture Series: Beyond conventional autofluorescence
B
09:15-09:30
C. von Strachwitz, Germany
B
09:30-09:45
Confocal blue reflectance and two-wavelengh fundus autofluorescence
P. Charbel Issa, UK
B
09:45-10:00 Discussion B
 
10:00-10:30 Coffee Break B
 
Session 16
10:30-12:00
Imaging II
 
Chairpersons: G. Staurenghi, Italy & H. Scholl, USA
Capsule:
High-resolution optical coherence tomography
B
10:30-11:15
Debate: Is SD-OCT necessary and sufficient to guide clinical decisions in neovascular AMD or diabetic macular edema?
B
10:30-10:45
U. Schmidt-Erfurth, Austria
B
10:45-11:00
No
J. Mones, Spain
B
11:00-11:15 Discussion B
11:15-12:00
Lecture Series: Combining SD-OCT with other imaging and functional technologies
B
11:15-11:30
SD-OCT and confocal reflectance imaging - evidence to support the combination
G. Staurenghi, Italy
B
11:30-11:45
H. Scholl, USA
B
11:45-12:00 Disucssion B
 
12:00-13:00
Glaucoma: A neurodegenerative disease
Lunch Session
(Garden Pavilion)
B
 
Session 17
13:00-14:30
Refractive Surgery
 
Chairpersons: J. Alio, Spain
Capsule:
Upper limits of corneal refractive surgery in myopia and hyperopia will be debated and discussed
B
13:00-13:45
Debate: Stretching the limits of excimer laser surgery: Lasik in high myopia, high hyperopia
B
13:00-13:15
High myopia
TBA
B
13:15-13:30
D. de Ortueta, Germany
B
13:30-13:45 Discussion B
13:45-14:30
Panel Discussion: Lens based refractive surgery
Moderator:
J. Alio, Spain
Panel:
D. de Ortueta, Germany
C. Verges, Spain
B
 
14:30-15:00 Coffee Break B
15:00-16:30
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
A
 
Session 18
16:30-18:00
Medical Retina II
 
Chairpersons: F. Bandello, Italy & A. Augustin, Germany
Capsule:
Vein occlusion and diabetic retinopathy
B
16:30-17:15
Debate: What is the first-line treatment of macular edema in retinal vein occlusion?
B
16:30-16:45
Corticosteroids
J. Mones, Spain
B
16:45-17:00
Anti-VEGF therapy
S. Bressler, USA
B
17:00-17:15
Panel Discussion:
1) How should me classify DME?
2) If we initiate anti-VEGF therapy for DME, should it be conbined with laser initially?
Moderator:
J. Mones, Spain
Panel:
S. Bressler, USA
B. Corcostegui, Spain
A. Pollack, Israel
G. Soubrane, France
B
17:15-18:00
Debate: What is the first-line treatment of macular edema in diabetic macular edema?
B
17:15-17:30
A. Augustin, Germany
B
17:30-17:45
Anti- VEGF therapy
N. Bressler, USA
B
17:45-18:00 Panel Discussion:
Moderator:
J. Cunha-Vaz, Portugal
Panel:
B. Corcostegui, Spain
B. Eldem, Turkey
A. Loewenstein, Israel
U. Schmidt-Erfurth, Austria
G. Soubrane, France
B
 
Session 19
08:30-10:00
Cornea I
 
Chairpersons: J. Alio, Spain & W.J. Stark, USA
Capsule:
Corneal ulcers 
C
08:30-09:00
Debate: Bacterial Corneal Ulcers
C
08:30-08:40
No need to culture
TBA
C
08:40-08:50
Culture is necessary
R. Barraquer, Spain
C
08:50-09:00 Disucssion C
09:00-09:30
Debate: First-line treatment in corneal ulcer
C
09:00-09:10
4th generation flouroquinolones
TBA
C
09:20-09:30 Discussion C
09:10-09:20
Fortified antibiotics
J.P. Alvarez de Toledo, Spain
C
09:30-10:00
Panel Discussion: Acanthameba infection
Moderator: J. Alio, Spain
Panel:
J.P. Alvarez de Toledo, Spain
R. Barraquer, Spain
C
 
10:00-10:30 Coffee Break C
 
Session 20
10:30-12:00
Uveitis
 
Chairpersons:
S. Lightman, UK & P. Sternberg, USA
Capsule:
JRA, ARN
C
10:30-11:00
Debate: Juvenile idiopathic arthritis
C
10:30-10:40
Phaco/IOL
S. Taylor, UK
C
10:40-10:50
Lensectomy vitrectomy
M. de Smet, The Netherlands
C
10:50-11:00 Discussion C
11:00-11:30
Debate: Treatment of ARN?
C
11:00-11:10
S. Lightman, UK
C
11:10-11:20
P. Sternberg, USA
C
11:20-11:30 Panel Discussion
Moderator:
S. Lightman, UK
Panel:
D. Jabs, USA
M. Kramer, Israel
P. Sternberg, USA
S. Taylor, UK
C
11:30-12:00
Debate: Mucous membrane pemphigoid: Treatment
C
11:30-11:40
D. Jabs, USA
C
11:40-11:50
M. Kramer, Israel
C
11:50-12:00 Discussion C
 
12:00-13:00
Glaucoma: A neurodegenerative disease
Lunch Session
(Garden Pavilion)
C
 
Session 21
13:00-14:30
Pediatrics II: Pediatric Ophthalmology
 
Chairpersons:
K.K. Nischal, UK & P. Nucci, Italy 
Capsule:
Controversies in pediatric external and anterior segment disease
C
13:00-13:45
Panel Discussion: Controversies in pediatric anterior segment surgery
Panel:
D. Bremond-Gignac, France
M. Morales Ballus, Spain
A. Serra Castanera, Spain
C
13:45-14:30
Panel Discussion: External disease
Panel:
D. Bremond-Gignac, France
J. Prat-Bartomeu, Spain
A. Serra Castanera, Spain
C
 
14:30-15:00 Coffee Break C
15:00-16:30
Symposium 
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
(Hall A)
C
 
Session 22
16:30-18:00
Cornea II
 
Chairpersons: W.J. Stark, USA & J. Alio, Spain
Capsule:
Modern keratoplasty techniques
C
16:30-17:00
Debate: Femtosecond keratoplasty: Is it worthwhile?
C
16:30-16:40
Yes
G. Baikoff, France
C
16:40-16:50
No
TBA
C
17:00-17:10 Lecture: Fuchs' Dystrophy and cataract: Cataract surgery alone or combined with endothelial replacement?
W.J. Stark, USA
C
17:10-17:35
Panel Discussion: Best method for keratoplasty - DSAEK, DMED, Descement menbrane keratoplasty or deep lameller keratoplasty?
Moderator:
W.J. Stark, USA
Panel:
J. Alio, Spain
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
C
17:35-18:00
Panel Discussion: Keratoprosthesis (Dohlman, Osteodental, Australian)
Moderator:
J. Alio, Spain
Panel:
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
C

Sunday, March 6, 2011

Time   Hall
 
Session 23
08:30-10:00
Tumors II
 
Chairpersons: J. Pe'er, Israel & L. Zografos, Switzerland
Capsule: Conjunctival tumors - diagnostic and therapeutic considerations
A
08:30-08:50
Debate: Ocular surface squamous neoplasia (OSSN) - How to treat?
A
08:30-08:38
N. Bechrakis, Austria
A
08:38-08:46
J. Pe'er, Israel
A
08:46-08:50 Discussion A
08:50-09:10 Debate: Primary acquired melanosis: Definition and approach
A
08:50-08:58 PAM is adequate and biopsy is unnecessary
T. Kivela, Finland
A
08:58-09:06 PAM is inadequate and biopsy is required
B. Damato, UK
A
09:06-09:10
Discussion
A
09:10-09:30 Debate: Large conjunctival melanoma - How to treat? A
09:10-09:18
B. Damato, UK
A
09:18-09:26
L. Desjardins, France
A
09:26-09:30 Discussion A
09:30-10:00
Controversies in the diagnostic approach and management of conjunctival tumors
Interesting cases with possible controversial approaches
Presenter:
J. Pe'er, Israel
Discussant:
L. Zografos, Switzerland
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
A
 
10:00-10:30 Coffee Break A
 
Session 24
10:30-12:30
Neuro-Ophthalmology II
 
Chairpersons: N. Miller, USA & M. Burdon, UK
Capsule:
Treatment issues
A
10:30-11:15
Point-Counterpoint: Medical Therapy in Neuro-ophthalmologic disorders
1) Should patients with NAION be treated with steroids?
Yes
A. Lee, USA
No
A. Arnold, USA
 
2) Should steroids be the first-line drug for patients with ocular myastenia gravis
Yes
N. Miller, USA
No
M. Burdon, UK
 
3) Should immunomodulary drugs be given to high-risk patients with optic neuritis and white-matter lesions on MR?
Yes
A. Arnold, USA
No
M. Burdon, UK
 
4) Topamax for IIH patients who cannot tolerate Diamox: Help or hype?
Helps
A. Lee, USA
Hype
M. Burdon, UK
A
11:15-12:30
Case Presentations
1) OMSM: When do you radiate?
A. Arnold, USA
 
2) Non-organic visual loss in an adult
A. Kesler, Israel
B. Sanchez-Dalmau, Spain
 
3) Non-organic visual loss in a child
A. Lee, USA
S. Muñoz, Spain
 
4) Steroid-dependent optic neuritis
M. Burdon, UK
L. Castillo, Spain
A
 
Session 25
08:30-10:00
Surgical Retina I
 
Moderators: A. Augustin, Germany; W. Mieler, USA & J. Moisseiev, Israel; P. Sternberg, USA
Capsule:
Changing trends in vitreo-retinal surgery
B
08:30-09:15
Debate: Does silicone oil still have a role in complicated RD with PVR?
B
08:30-08:45
W. Mieler, USA
B
08:45-09:00
S. Rizzo, Italy
B
09:00-09:15 Discussion B
09:15-10:00
Debate: Should we perform pneumatic retinopexy?
B
09:15-09:30
Pro: Pneumatic retinopexy is a safe and effective treatment for RD
F. Boscia, Italy
B
09:30-09:45
J. Nawrocki, Poland
B
09:45-10:00 Discussion B
 
10:00-10:30 Coffee Break B
 
Session 26
10:30-12:30
Surgical Retina II
 
Moderators: A. Augustin, Germany; F. Boscia, Italy; W. Mieler, USA & J. Moisseiev, Israel
Capsule:
Macular surgery
B
10:30-11:10
Debate: Prone positioning after vitrectomy for macular hole: Is it really necessary?
B
10:30-10:45
J. Nawrocki, Poland
B
10:45-11:00
P. Sternberg, USA
B
11:00-11:10 Discussion B
11:10-11:50
Debate: Should we operate an ERM with good VA and what technique should we use?
B
11:10-11:25
J. Moisseiev, Israel
B
11:25-11:40
Con: ERM peeling should be performed with VA worse than 20/50
W. Meiler, USA
B
11:40-11:50 Discussion B
11:50-12:00
Case Presentation with Panel Discussion
(2-3 cases)
Presenter:
J. Moisseiev, Israel
Panel:
A. Augustin, Germany
W. Mieler, USA
J. Nawrocki, Poland
P. Sternberg, USA
B

Home   
Copyright © 2008 Comtecmed.com. All rights reserved.   The website was last updated on 03/31/2011 Created by    WebStudio.co.il